Published in J Clin Invest on April 01, 1966
Stimulation of aldosterone biosynthesis in adrenal mitochondria by sodium depletion. J Clin Invest (1967) 1.01
Recurrent hyperkalaemia due to selective aldosterone deficiency: correction by angiotensin infusion. Br Med J (1973) 0.99
Plasma cortisol levels in heart failure. Br Med J (1967) 0.96
Sites of action of sodium depletion on aldosterone biosynthesis in the dog. J Clin Invest (1968) 0.94
Adrenocortical steroidogenesis: studies on the mechanism of action of angiotensin and electrolytes. J Clin Invest (1972) 0.94
Studies of the control of plasma aldosterone concentration in normal man. 3. Response to sodium chloride infusion. J Clin Invest (1972) 0.92
Site of stimulation of aldosterone biosynthesis by angiotensin and potassium. J Clin Invest (1972) 0.86
The regulation of aldosterone secretion in anephric man. J Clin Invest (1971) 0.85
Reduction of gastric acid secretion on a low-salt diet and furosemide. Gut (1969) 0.82
The role of the renin-angiotensin system in the control of aldosterone secretion. Proc R Soc Med (1969) 0.75
Double isotope derivative assay of aldosterone in biological extracts. J Biol Chem (1960) 6.19
The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man. Trans Assoc Am Physicians (1958) 2.48
Angiotensin, aldosterone and human arterial hypertension. Can Med Assoc J (1961) 2.15
Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion. J Clin Invest (1961) 2.14
Evidence for secretion of an aldosterone-stimulating hormone by the kidney. J Clin Invest (1961) 2.13
PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES. J Clin Invest (1965) 1.94
Increased aldosterone output during sodium deprivation in normal men. Proc Soc Exp Biol Med (1954) 1.92
Dual mechanism regulating adrenocortical function in man. Am J Med (1956) 1.88
THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE. J Clin Invest (1961) 1.84
The nature of the aldosterone-stimulating factor in dog kidneys. J Clin Invest (1962) 1.72
Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11 beta-hydroxylation. J Clin Endocrinol Metab (1958) 1.70
The effect of ACTH, renin, angiotensin II, and various precursors on biosynthesis of aldosterone by adrenal slices. J Clin Invest (1962) 1.58
AN ALDOSTERONE BIOSYNTHETIC DEFECT IN A SALT-LOSING DISORDER. J Clin Endocrinol Metab (1964) 1.40
INFLUENCE OF THE PITUITARY AND THE RENIN-ANGIOTENSIN SYSTEM ON THE SECRETION OF ALDOSTERONE, CORTISOL, AND CORTICOSTERONE. J Clin Invest (1963) 1.31
Some studies on the biosynthesis of aldosterone and other adrenal steroids. Acta Endocrinol (Copenh) (1960) 1.04
A NEW HEREDITARY DEFECT IN THE BIOSYNTHESIS OF ALDOSTERONE: URINARY C21-CORTICOSTEROID PATTERN IN THREE RELATED PATIENTS WITH A SALT-LOSING SYNDROME, SUGGESTING AN 18-OXIDATION DEFECT. Acta Endocrinol (Copenh) (1964) 1.01
In vitro biosynthesis of isotopic aldosterone: comparison of precursors. Endocrinology (1958) 0.98
MODIFICATION OF ALDOSTERONE SECRETION AND ELECTROLYTE EXCRETION IN MAN BY A CHEMICAL INHIBITOR OF 18-OXIDATION. J Clin Endocrinol Metab (1964) 0.92
CONVERSION OF TRITIATED-18-HYDROXYCORTICOSTERONE TO ALDOSTERONE BY SLICES OF HUMAN CORTICO-ADRENAL GLAND AND ADRENAL TUMOUR. Nature (1964) 0.84
Effects of triparanol on the secretion and metabolism of adrenal corticosteroids. J Clin Endocrinol Metab (1962) 0.79
Normal and abnormal regulation of beta-msh in man. J Clin Invest (1969) 2.68
Radioimmunoassay of beta-MSH in human plasma and tissues. J Clin Invest (1967) 2.44
Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. J Clin Invest (1970) 2.18
Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res (1969) 2.16
The ectopic ACTH syndrome. Cancer Res (1965) 1.97
Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. J Clin Invest (1970) 1.86
Results of treatment in 108 patients with Cushing's syndrome. N Engl J Med (1971) 1.69
Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action. J Clin Endocrinol Metab (1967) 1.68
Light synchronization of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. J Clin Endocrinol Metab (1969) 1.54
Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest (1972) 1.52
Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine. J Clin Invest (1970) 1.49
Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J Clin Invest (1967) 1.42
Measurement of renin in both renal veins. Its use in diagnosis of renovascular hypertension. Arch Intern Med (1967) 1.33
A diurnal rhythm in plasma renin activity in man. J Clin Invest (1966) 1.32
Adenosine 3',5'-monophosphate (cyclic AMP) as the mediator of the actions of melanocyte stimulating hormone (MSH) and norepinephrine on the frog skin. Endocrinology (1969) 1.29
In vitro stimulation of renin production by epinephrine, norepinephrine, and cyclic AMP. Proc Soc Exp Biol Med (1969) 1.28
The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone. Arch Intern Med (1972) 1.23
Effect of diazoxide on plasma renin activity in hypertensive patients. Ann Intern Med (1967) 1.22
Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab (1973) 1.20
Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. J Clin Invest (1974) 1.18
Results of treating childhood Cushing's disease with pituitary irradiation. N Engl J Med (1977) 1.17
Biologic and immunologic characterization and physical separation of ACTH and ACTH fragments in the ectopic ACTH syndrome. J Clin Invest (1973) 1.17
Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men. J Clin Invest (1974) 1.17
ACTH antibodies in patients receiving depot porcine ACTH to hasten recovery from pituitary-adrenal suppression. J Clin Invest (1967) 1.16
Studies of ACTH antibodies and their reactions with inactive analogues of ACTH. Endocrinology (1966) 1.15
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest (1983) 1.14
Graves' disease without hyperthyroidism. Am J Med (1965) 1.14
Effects of amino-glutethimide on adrenal function in man. J Clin Endocrinol Metab (1967) 1.14
A method of preparing adrenal cell suspensions and its applicability to the in vitro study of adrenal metabolism. Endocrinology (1968) 1.13
Measurement of urinary free corticoids by competitive protein-binding radioassay in hypoadrenal states. J Clin Endocrinol Metab (1970) 1.12
ACTH and MSH production by a single cloned mouse pituitary tumor cell line. Endocrinology (1973) 1.11
Radioimmunologic evidence for alpha-MSH (melanocyte stimulating hormone) in human pituitary and tumor tissues. J Clin Endocrinol Metab (1967) 1.10
Differences between ectopic MSH and pituitary MSH. J Clin Endocrinol Metab (1971) 1.06
Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonin on frog skin color. Endocrinology (1969) 1.06
Comparative effects of angiotensin and ACTH on cyclic AMP and steroidogenesis in isolated bovine adrenal cells. J Clin Invest (1973) 1.04
Comparative fates of intravenously and orally administered aldosterone: evidence for extrahepatic formation of acid-hydrolyzable conjugate in man. J Clin Invest (1966) 1.03
Effect of an adrenal inhibitor in hypertensive patients with suppressed renin. Arch Intern Med (1969) 1.02
Single daily dose prednisone therapy. JAMA (1979) 1.01
Extracellular cyclic nucleotides. Ann N Y Acad Sci (1971) 1.01
Surgical experience with Cushing's disease. Ann Surg (1977) 1.01
Analysis of circadian rhythms in human adrenocortical secretory activity. Arch Intern Med (1966) 0.99
An analysis of factors determining the circadian pattern of aldosterone excretion. J Clin Endocrinol Metab (1966) 0.98
Reversible adrenal insufficiency induced by ketoconazole. JAMA (1985) 0.98
A simple test for selecting the thioamide schedule in thyrotoxicosis. J Clin Endocrinol Metab (1972) 0.98
Identification of a naturally occurring goitrogen in water. Trans Assoc Am Physicians (1969) 0.97
Surgical management of adrenocortical tumors with Cushing's syndrome. Ann Surg (1971) 0.97
Inhibitors of adrenal steroid biosynthesis. Annu Rev Pharmacol (1970) 0.97
An effect of adrenocorticotrophic hormone on adrenal cholesterol accumulation. Endocrinology (1967) 0.96
Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency. N Engl J Med (1969) 0.96
Preliminary characterization of the pituitary melanocyte stimulating hormones of several vertebrate species. Endocrinology (1972) 0.95
Cyclic adenosine monophosphate as a mediator of hormone action. N Engl J Med (1971) 0.95
Adverse respiratory outcomes associated with occupational exposures at a soy processing plant. Eur Respir J (2010) 0.95
Plasma renin activity and aldosterone secretion in a pregnant woman with primary aldosteronism. J Clin Endocrinol Metab (1967) 0.94
Stimulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by o,p'-DDD. Biochem Pharmacol (1982) 0.94
An explanation for the target organ unresponsiveness to testosterone in the testicular feminization syndrome. J Clin Endocrinol Metab (1969) 0.94
Cimetidine alters plasma catecholamine levels and cortisol and aldosterone excretion. N Engl J Med (1982) 0.93
Hyperprolactinemia associated with advanced puberty in a male. J Pediatr (1982) 0.92
Progressive multifocal leukoencephalopathy in a child with severe combined immunodeficiency. N Engl J Med (1978) 0.92
Aldosterone antagonists and triamterene. Ann N Y Acad Sci (1966) 0.92
Cushing's syndrome. Ann N Y Acad Sci (1977) 0.92
Pathogenesis of glucocorticoid disorders. Am J Med (1972) 0.90
Experimental alteration of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. J Clin Endocrinol Metab (1967) 0.88
Angiotensin stimulates both early and late steps in aldosterone biosynthesis in isolated bovine glomerulosa cells. J Steroid Biochem (1978) 0.87
Site of stimulation of aldosterone biosynthesis by angiotensin and potassium. J Clin Invest (1972) 0.86
A comparison of primary care educational experiences in two urban pediatric settings. Annu Conf Res Med Educ (1977) 0.86
Modulation of plasma aldosterone concentration by plasma potassium in anephric man in the absence of a change in potassium balance. J Clin Invest (1973) 0.86
Stimulation of adrenal ornithine decarboxylase by adrenocorticotropin and growth hormone. Endocrinology (1973) 0.85
The effects of potassium on early and late steps in aldosterone biosynthesis in cells of the zona glomerulosa. Endocrinology (1978) 0.85
Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal cells. J Clin Invest (1979) 0.85
Surgical experience with hyperparathyroidism. Am Surg (1981) 0.85
Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab (1987) 0.85
A predictable error in use of renal vein renin in diagnosing hypertension. Arch Intern Med (1969) 0.85
Plasma deoxycorticosterone in normal and abnormal pregnancy. J Clin Endocrinol Metab (1972) 0.85
Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab (1976) 0.84
Preliminary characterization of some ectopic hormones. Vitam Horm (1968) 0.83
Proceedings of the fifty-ninth annual meeting of the American Society for Clinical Investigation, Inc., held in Atlantic City, N. J., May 1, 1967. Presidential address. The mores of clinical investigation. J Clin Invest (1967) 0.83
Studies on mechanism of cyproheptadine-induced weight gain in human subjects. Metabolism (1970) 0.83
Studies of the elevated extracellular concentration of cyclic AMP in uremic man. J Clin Invest (1975) 0.82
Circulating levels of angiotensin I measured by radioimmunoassay in hypertensive subjects. J Lab Clin Med (1979) 0.82